Para esto el deep research si que mola mucho.
Mi prompt con Deep Research ON
PFE just announced this: "NEW YORK–(BUSINESS WIRE)–
Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive
global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a
leading Chinese biopharmaceutical company, for the development,
manufacturing and commercialization of SSGJ-707, a bispecific antibody
targeting PD-1 and VEGF, currently undergoing several clinical trials in
China for non-small cell lung cancer, metastatic colorectal cancer, and
gynecological tumors. SSGJ-707 has shown initial efficacy and safety
data in a promising class of cancer medicines. 3SBio plans to initiate
the first Phase 3 study in China in 2025.
Under the terms of the
agreement, 3SBio and its subsidiaries Shenyang Sunshine Pharmaceutical
Co., Ltd. and 3S Guojian Pharmaceutical (Shanghai) Co., Ltd. will grant
Pfizer an exclusive global license to develop, manufacture and
commercialize SSGJ-707 worldwide, excluding China. The agreement also
provides Pfizer the option of commercialization rights in China. 3SBio
will receive an upfront payment of $1.25 billion and is eligible to
receive milestone payments associated with certain development,
regulatory and commercial milestones up to $4.8 billion as well as
tiered double-digit royalties on sales of SSGJ-707, if approved.
The
transaction is expected to close in the third quarter subject to
fulfillment of customary closing conditions, including receipt of
required regulatory approvals and 3SBio shareholder approval. Upon
close, Pfizer will make a $100 million equity investment in 3SBio
subject to an agreed upon securities subscription agreement between the
parties. Pfizer plans to manufacture drug substance for SSGJ-707 in
Sanford, North Carolina, and drug product in McPherson, Kansas." find out about the company and find out about the product that PFE is buying. What could be the TAM, price and margins? Explain and compare with existing therapies. Pro and cons. How can it penetrate the market? why? Make an investment analysis.
